Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke

Abstract Background: Combined therapy with epidermal growth factor (EGF) and growth hormone-releasing peptide 6 (GHRP-6) in stroke models has accumulated evidence of neuroprotective effects from several studies, but needs further support before clinical translation. Comparing EGF + GHRP-6 to hypothermia, a gold neuroprotection standard, may contribute to this purpose. Objectives: The aims of this study were to compare the neuroprotective effects of a combined therapy based on EGF + GHRP-6 with hypothermia in animal models of (a) global ischemia representing myocardial infarction and (b) focal brain ischemia representing ischemic stroke. Methods: (a) Global ischemia was induced in Mongolian gerbils by a 15-min occlusion of both carotid arteries, followed by reperfusion. (b) Focal brain ischemia was achieved by intracerebral injection of endothelin 1 in Wistar rats. In each experiment, three ischemic treatment groups – vehicle, EGF + GHRP-6, and hypothermia – were compared to each other and to a sham-operated control group. End points were survival, neurological scores, and infarct volume. Results: (a) In global ischemia, neurological score at 48–72 h, infarct volume, and neuronal density of hippocampal CA1 zone in gerbils treated with EGF + GHRP-6 were similar to the hypothermia-treated group. (b) In focal ischemia, the neurologic score and infarct volume of rats receiving EGF + GHRP-6 were also similar to animals in the hypothermia group. Discussion: With hypothermia being a good standard neuroprotectant reference, these results provide additional proof of principle for EGF and GHRP-6 co-administration as a potentially neuroprotective stroke therapy.

[1]  A. Bitto,et al.  Vagus Nerve Mediates the Protective Effects of Melanocortins against Cerebral and Systemic Damage after Ischemic Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Myron D. Ginsberg,et al.  Neuroprotection for ischemic stroke: Past, present and future , 2008, Neuropharmacology.

[3]  H. Bramlett,et al.  Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. , 2009, Journal of neurotrauma.

[4]  R. Wong,et al.  The role of epidermal growth factor and its receptors in mammalian CNS. , 2004, Cytokine & growth factor reviews.

[5]  P. López-Saura,et al.  Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation , 2007, International wound journal.

[6]  J. Grotta,et al.  Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L): Final Results , 2010, Stroke.

[7]  J. Fernández-Montequín,et al.  Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure , 2009, International wound journal.

[8]  M. Yenari,et al.  Therapeutic hypothermia: neuroprotective mechanisms. , 2007, Frontiers in bioscience : a journal and virtual library.

[9]  E. Samaniego.  Therapeutic Hypothermia in Acute Stroke , 2013 .

[10]  C. Brodie,et al.  Growth factors attenuate the cholinotoxic effects of ethanol during early neuroembryogenesis in the chick embryo , 1991, International Journal of Developmental Neuroscience.

[11]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[12]  A. Annenkov.  The Insulin-Like Growth Factor (IGF) Receptor Type 1 (IGF1R) as an Essential Component of the Signalling Network Regulating Neurogenesis , 2009, Molecular Neurobiology.

[13]  J. Krupiński,et al.  Increased Expression of TGF-β1 in Brain Tissue After Ischemic Stroke in Humans , 1996 .

[14]  D. Krieger,et al.  Hypothermia for Acute Ischemic Stroke: Not Just Another Neuroprotectant , 2003, The neurologist.

[15]  X. Ji,et al.  Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapy , 2015, Neurological research.

[16]  D. Krieger,et al.  Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke , 2001, Stroke.

[17]  J. Krupiński,et al.  Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. , 1996, Stroke.

[18]  M. Ginsberg.  Current status of neuroprotection for cerebral ischemia: synoptic overview. , 2009, Stroke.

[19]  G. Werther,et al.  Growth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: a potential role for growth hormone in injury-induced neurogenesis. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[20]  Jorge Amador Berlanga Acosta,et al.  Epidermal growth factor and growth hormone-releasing peptide-6: combined therapeutic approach in experimental stroke. , 2013, Restorative neurology and neuroscience.

[21]  R. Bradshaw,et al.  Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. , 1987, Science.

[22]  K. Reymann,et al.  Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia , 2005, Brain Research.

[23]  D. Corbett,et al.  An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat , 2006, Experimental Neurology.

[24]  H. Nawa,et al.  Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons , 2006, Molecular and Cellular Neuroscience.

[25]  Assessment of dose–effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy , 2016, Neurological research.

[26]  H. Ovadia,et al.  Re: Feasibility and safety of moderate hypothermia after massive hemispheric infarction. , 2001, Stroke.

[27]  B. Lin,et al.  Intraischemic but not postischemic hypothermia prevents non-selective hippocampal downregulation of AMPA and NMDA receptor gene expression after global ischemia. , 2001, Brain research. Molecular brain research.

[28]  B. Liu,et al.  Activation of epidermal growth factor receptors directs astrocytes to organize in a network surrounding axons in the developing rat optic nerve. , 2004, Developmental biology.

[29]  X. Tang,et al.  Hypothermia as a cytoprotective strategy in ischemic tissue injury , 2010, Ageing Research Reviews.

[30]  J. Argente,et al.  Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats , 2003, Neuroreport.

[31]  Yuxiang Sun,et al.  Growth hormone secretagogues: prospects and potential pitfalls. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[32]  H. Hayashi,et al.  Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System. , 2015, Biological & pharmaceutical bulletin.

[33]  B. Liu,et al.  Activation of epidermal growth factor receptors in astrocytes: From development to neural injury , 2007, Journal of neuroscience research.

[34]  Liping Liu,et al.  Clinical application of therapeutic hypothermia in stroke , 2009, Neurological research.

[35]  G. Steinberg,et al.  The Protective Effect of Early Hypothermia on PTEN Phosphorylation Correlates with Free Radical Inhibition in Rat Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  L. Lazar,et al.  Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-alpha mRNA in mouse brain by a quantitative nuclease protection assay , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  C. McGraw,et al.  Effect of DPPD (Diphenyl-para-Phenylenediamine) on Stroke and Cerebral Edema in Gerbils , 1978, Stroke.

[38]  R. Ochs,et al.  Epidermal growth factor and 12-O-tetradecanoylphorbol 13-acetate stimulate lactate production and the pentose phosphate pathway in freshly isolated rat hepatocytes. , 1990, The Journal of biological chemistry.

[39]  D. Cibrian,et al.  Therapeutic Effect of the Combined Use of Growth Hormone Releasing Peptide-6 and Epidermal Growth Factor in an Axonopathy Model , 2010, Neurotoxicity Research.

[40]  E. Montero,et al.  Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis. , 2011, Restorative neurology and neuroscience.

[41]  J. S. Alba,et al.  Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. , 2007, Clinical science.

[42]  J. Argente,et al.  Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. , 2002, Endocrinology.

[43]  H. Ehrenreich,et al.  Neuroprotection – what does it mean? – what means do we have? , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[44]  P. Lyden,et al.  Induced Hypothermia for Acute Stroke , 2007, Stroke.

[45]  R. Playford,et al.  Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. , 2006, Clinical science.

[46]  S. Schwab,et al.  Hypothermia in acute stroke—Slow versus fast rewarming An experimental study in rats , 2007, Experimental Neurology.

[47]  W. Stummer,et al.  Reduced Mortality and Brain Damage After Locomotor Activity in Gerbil Forebrain Ischemia , 1994, Stroke.

[48]  J. Chowen,et al.  Basic physiology of the growth hormone/insulin-like growth factor axis. , 2005, Advances in experimental medicine and biology.

[49]  A. Buchan,et al.  Neuroprotection for Stroke: Current Status and Future Perspectives , 2012, International journal of molecular sciences.

[50]  D. Åberg.  Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. , 2010, Endocrine development.

[51]  Shijie Sun,et al.  Therapeutic hypothermia after cardiac arrest in adults: mechanism of neuroprotection, phases of hypothermia, and methods of cooling. , 2012, Critical care clinics.

[52]  S. Mayer,et al.  Feasibility and Safety of Moderate Hypothermia After Massive Hemispheric Infarction , 2001, Stroke.

[53]  F. Casanueva,et al.  Growth Hormone Secretagogues: The Clinical Future , 1999, Hormone Research in Paediatrics.

[54]  B. McColl,et al.  Experimental Stroke-Induced Changes in the Bone Marrow Reveal Complex Regulation of Leukocyte Responses , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  P. López-Saura,et al.  Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents. , 2002, Burns : journal of the International Society for Burn Injuries.

[56]  I. Fabregat,et al.  EGF blocks NADPH oxidase activation by TGF‐β in fetal rat hepatocytes, impairing oxidative stress, and cell death , 2006, Journal of cellular physiology.

[57]  P. Mccombe,et al.  Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability , 2012, Journal of Neuroimmunology.

[58]  R. Derynck,et al.  Multiple trophic actions of heparin‐binding epidermal growth factor (HB‐EGF) in the central nervous system , 1999, The European journal of neuroscience.

[59]  R. Dempsey,et al.  Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus , 2005, Neurochemistry International.

[60]  S. Murong,et al.  Mild hypothermia reduces ischemic neuron death via altering the expression of p53 and bcl-2 , 2010, Neurological research.

[61]  A. Kakita,et al.  ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex , 2005, Neuroscience.

[62]  F. Buonanno,et al.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment , 2013, Neurological research.

[63]  R. Playford,et al.  Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. , 2002, The American journal of pathology.

[64]  M. Baudry,et al.  Brain-Derived Neurotrophic Factor and Epidermal Growth Factor Activate Neuronal m-Calpain via Mitogen-Activated Protein Kinase-Dependent Phosphorylation , 2010, The Journal of Neuroscience.

[65]  I. Varela-Nieto,et al.  The Growth Hormone/Insulin-Like Growth Factor Axis During Development , 2005 .

[66]  Jun Li,et al.  Post-stroke hypothermia provides neuroprotection through inhibition of AMP-activated protein kinase. , 2011, Journal of neurotrauma.

[67]  Hyung Soo Han,et al.  Neuroprotective mechanisms of hypothermia in brain ischaemia , 2012, Nature Reviews Neuroscience.

[68]  C. Bowers,et al.  Growth hormone-releasing peptide (GHRP) , 1998, Cellular and Molecular Life Sciences CMLS.

[69]  S. Starkman,et al.  Neuroprotective agents for the treatment of acute ischemic stroke , 2003, Current neurology and neuroscience reports.

[70]  A. Buchan,et al.  Neuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside , 2012, International journal of stroke : official journal of the International Stroke Society.

[71]  N. Knuckey,et al.  Efficacy of mild hypothermia (35°C) and moderate hypothermia (33°C) with and without magnesium when administered 30min post-reperfusion after 90min of middle cerebral artery occlusion in Spontaneously Hypertensive rats , 2013, Brain Research.